Testing Standards

This page explains how Pexrit Labs describes and publishes laboratory evidence so that testing claims stay aligned with the actual reports.

Current Analytical Scope

The current public Vanguard Laboratory reports for the seven listed 10MG samples document:

  • Chromatographic purity by HPLC-UV/VIS
  • Measured quantity by HPLC-UV/VIS
  • Laboratory ID
  • Lot number shown on the submitted report
  • Date reported

Current Inventory Lot Matching

Pexrit Labs confirms that the current vials are labeled with the same lot numbers shown on the corresponding reports. This is a Pexrit Labs inventory and labeling confirmation and does not expand the analytical scope of the laboratory reports.

Current Report Results

Product / tested strength Laboratory ID Lot on report Chromatographic purity Measured quantity
Tirzepatide 10MG V260601-26 001 PX-TIRZ-250526-01 >99.80% + 0.18% 10.70 mg
Retatrutide 10MG V260601-26 002 PX-RETA-250526-01 98.86% + 0.18% 11.74 mg
Semaglutide 10MG V260601-26 003 PX-SEMA-250526-01 99.11% + 0.18% 10.30 mg
BPC-157 10MG V260601-26 004 PX-BPC157-250526-01 >99.80% + 0.18% 11.09 mg
TB-500 10MG V260601-26 005 PX-TB500-250526-01 >99.80% + 0.18% 10.95 mg
Ipamorelin 10MG V260601-26 006 PX-IPA-250526-01 97.55% + 0.18% 10.13 mg
Tesamorelin 10MG V260601-26 007 PX-TESA-250526-01 99.05% + 0.18% 10.74 mg

No Implied Testing

Pexrit Labs does not treat a purity/quantity report as evidence of identity, sterility, endotoxin, microbiological, or other testing unless that analysis is explicitly listed on the report itself.

Sample and Lot Limitations

The Vanguard Laboratory reports state that results relate only to the tested portion of the sample and that the laboratory did not observe or participate in sample selection. The reports further state that the laboratory cannot confirm the authenticity of the sample or its representativeness of the associated lot or batch.

Pexrit Labs' current-lot statement above is therefore a merchant inventory and labeling statement, not an expansion of what Vanguard independently verified.

Strength-Specific Reports

Where Pexrit Labs sells more than one strength of a product, a report for one strength is not presented as evidence of the quantity of another strength. At present, the public Tirzepatide and Retatrutide reports correspond to 10MG tested samples; separate public reports for their larger listed strengths are not currently published.

Research Use Only

Products are intended solely for laboratory research and in vitro testing and are not intended for human or animal use.